Anavex Braces For EU Rejection Of Alzheimer’s Drug As Six Other Products Await EMA Verdict

 
• By Francesca Bruce
  
The European Medicines Agency's human medicines committee is expected to whether seven new medicines should be authorized in the EU. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from EU CHMP

More from Europe